W. M. Scheld and M. A. Sande, “Bactericidal versus Bacteriostatic Antibiotic Therapy of Experimental Pneumococcal Meningitis in Rabbits,” Journal of Clinical Investigation, Vol. 71, No. 3, 1983, pp. 411-419.
 J. P. Sculier and J. Klastersky, “Significance of Serum Bactericidal Activity in Gram-Negative Bacillary Bacteremia in Patients with and without Granulocytopenia,” American Journal of Medicine, Vol. 76, No. 3, 1984, pp. 429-435. doi:10.1016/0002-9343(84)90662-4
 Clinical and Laboratory Institute, “Methods for Determining Bactericidal Activity of Antimicrobial Agents,” Approved Guideline, CLSI Document M26-A, Wayne, 1999.
 S. Handwerger and A. Tomaz, “Antibiotic Tolerance among Clinical Isolates of Bacteria,” Reviews of Infectious Diseases, Vol. 7, No. 3, 1985, pp. 368-386.
 G. A. Pankey and L. D. Sabath, “Clinical Relevance of Bacteriostatic versus Bactericidal Mechanisms of Action in the Treatment of Gram Positive Bacterial Infections,” Clinical Infectious Diseases, Vol. 38, No. 6, 2004, pp. 864-870. doi:10.1086/381972
 Clinical and Laboratory Institute, “Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically,” 6th Edition, CLSI Document M7-A6, Wayne, 2003.
 Clinical and Laboratory Institute, “Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts,” 3rd Edition, CLSI Document M27-A2, Wayne, 2002.
 Clinical and Laboratory Institute, “Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi,” 2nd Edition, CLSI Document M38-A, Wayne, 2008.
 A. L. Barry and R. A. Lasner, “In Vitro Methods for Determining Minimum Lethal Concentrations of Antibacterial Agents,” American Journal of Clinical Pathology, Vol. 71, No. 1, 1979, pp. 88-92.
 J. Dankert, Y. Holloway, W. Joldersma and J. Hess, “Important of Minimizing Carry over Effect at Subculture in the Detection of Penicillin Tolerant Viridans Group Streptococci,” Antimicrobial Agents and Chemotherapy, Vol. 23, No. 4, 1983, pp. 232-235.